Follow the 인바이오젠 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). The latest transaction was disclosed on 7 January 2025 (Sale). Among the most active insiders: 버킷스튜디오. All data is free.
38
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
20 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Inbiozen es una empresa que cotiza en la bolsa de valores XKRX, especializada en el sector biofarmacéutico. Se centra en el desarrollo de tratamientos innovadores para diversas enfermedades.